155 related articles for article (PubMed ID: 18758416)
1. Predictive factors of carcinoma in 327 patients with follicular neoplasm of the thyroid.
Besic N; Sesek M; Peric B; Zgajnar J; Hocevar M
Med Sci Monit; 2008 Sep; 14(9):CR459-67. PubMed ID: 18758416
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum thyroglobulin concentration is an independent predictive factor of malignancy in follicular neoplasms of the thyroid gland.
Petric R; Perhavec A; Gazic B; Besic N
J Surg Oncol; 2012 Mar; 105(4):351-6. PubMed ID: 21751218
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors of carcinoma in 279 patients with Hürthle cell neoplasm of the thyroid gland.
Strazisar B; Petric R; Sesek M; Zgajnar J; Hocevar M; Besic N
J Surg Oncol; 2010 Jun; 101(7):582-6. PubMed ID: 20461764
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum thyroglobulin concentration as a predictive factor of malignancy in small follicular and Hürthle cell neoplasms of the thyroid gland.
Petric R; Besic H; Besic N
World J Surg Oncol; 2014 Sep; 12():282. PubMed ID: 25213012
[TBL] [Abstract][Full Text] [Related]
5. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid.
Suh I; Vriens MR; Guerrero MA; Griffin A; Shen WT; Duh QY; Clark OH; Kebebew E
Am J Surg; 2010 Jul; 200(1):41-6. PubMed ID: 20637335
[TBL] [Abstract][Full Text] [Related]
6. Risk of malignancy in follicular thyroid neoplasm: predictive value of thyrotropin.
Zimny M; Selkinski I; Blasius S; Rink T; Schroth HJ; Grünwald F
Nuklearmedizin; 2012; 51(4):119-24. PubMed ID: 22526481
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
[TBL] [Abstract][Full Text] [Related]
8. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.
Shoup M; Stojadinovic A; Nissan A; Ghossein RA; Freedman S; Brennan MF; Shah JP; Shaha AR
J Am Coll Surg; 2003 Aug; 197(2):191-7. PubMed ID: 12892796
[TBL] [Abstract][Full Text] [Related]
9. Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis.
Lin KD; Lin JD; Huang MJ; Huang HS; Jeng LB; Chao TC; Ho YS
Int Surg; 1997; 82(4):378-81. PubMed ID: 9412835
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
[TBL] [Abstract][Full Text] [Related]
11. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
12. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
13. Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
Lin JD; Chao TC; Chen ST; Huang YY; Liou MJ; Hsueh C
Surg Oncol; 2007 Aug; 16(2):107-13. PubMed ID: 17600699
[TBL] [Abstract][Full Text] [Related]
14. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
[TBL] [Abstract][Full Text] [Related]
15. The value of frozen section in intraoperative surgical management of thyroid follicular carcinoma.
Dosen D; Turić M; Smalcelj J; Janusić R; Grgić MP; Separović V
Head Neck; 2003 Jul; 25(7):521-8. PubMed ID: 12808654
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
[TBL] [Abstract][Full Text] [Related]
17. The relation between pure papillary and follicular variant in papillary thyroid carcinoma.
Yuksel O; Kurukahvecioglu O; Ege B; Ekinci O; Aydin A; Poyraz A; Tezel E; Taneri F
Endocr Regul; 2008 Mar; 42(1):29-33. PubMed ID: 18333702
[TBL] [Abstract][Full Text] [Related]
18. Non-suppressible TSH in a patient thyroidectomized due to follicular thyroid carcinoma.
Gessl A; Vierhapper H; Feichtinger H
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):389-92. PubMed ID: 16915543
[TBL] [Abstract][Full Text] [Related]
19. Is thyroglobulin the stronger indicator for progressive disease than the other conventional factors in same age patient groups with differentiated thyroid cancer?
Aras G; Gültekin SS; Küçük NO; Genç Y
Nucl Med Commun; 2007 Dec; 28(12):907-13. PubMed ID: 18090216
[TBL] [Abstract][Full Text] [Related]
20. Role of serum thyroglobulin in the pre-operative evaluation of follicular thyroid tumours.
Hocevar M; Auersperg M
Eur J Surg Oncol; 1998 Dec; 24(6):553-7. PubMed ID: 9870733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
